Combinations of riluzole and levodopa for the treatment of Parkinson's disease
US6387936B1 · kind B1 · utility
14Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 24, 2000 |
| Grant date | May 14, 2002 |
| Priority date | — |
| Expiry date | Oct 24, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns a combination of levodopa and riluzole or a pharmaceutically acceptable salt of said compound and the use of said combination for treating Parkinson Disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.